EODData

MEMBERSHIP REGISTER LOG IN

FRA, 3ZO: ACURX PHARMACEUT. DL-001

02 Sep 2025
LAST:

5.090

CHANGE:
 0.00		OPEN:
5.090		HIGH:
5.090		ASK:
0.000		VOLUME:
0
CHG(%):
0.00		PREV:
5.090		LOW:
5.090		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Sep 255.0905.0905.0905.0900
01 Sep 255.0905.0905.0905.0900
29 Aug 255.0905.0905.0905.0900
28 Aug 255.0905.0905.0905.0900
27 Aug 255.0905.0905.0905.0900
26 Aug 255.0905.0905.0905.0900
25 Aug 255.0905.0905.0905.0900
22 Aug 255.0905.0905.0905.0900
21 Aug 255.0905.0905.0905.0900
20 Aug 255.0905.0905.0905.0900

COMPANY PROFILE

Name:ACURX PHARMACEUT. DL-001
About:Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Sector:Healthcare
Industry:Biotechnology
Address:259 Liberty Avenue, Staten Island, NY, United States, 10305
Website:https://www.acurxpharma.com
ISIN:US00510M1045

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:5.09
MA10:5.09
MA20:5.09
MA50:2.25
MA100:1.41
MA200:1.10
Week High:5.09
Week Low:5.09
Month High:5.11
Month Low:0.25
Year High:5.11
Year Low:0.01
Volatility:1,547.23

RECENT SPLITS

Date Ratio
05 Aug 20251-20